Table 5.
Indication | Total | IVF-ET | Controls | |||
---|---|---|---|---|---|---|
N=44 | (%) | N=30 | (%) | N=14 | (%) | |
Advanced maternal age at first pregnancy | 12 | 27.27 | 10 | 22.73 | 2 | 4.55 |
IVF or precious pregnancy | 8 | 18.18 | 8 | 18.18 | 0 | 0 |
Acute Fetal Distress | 5 | 11.36 | 3 | 6.82 | 2 | 4.55 |
PMTCT (HIV) | 1 | 2.27 | 0 | 0 | 1 | 2.27 |
Abruption Placenta | 1 | 2.27 | 1 | 2.27 | 0 | 0 |
Others | 17 | 38.64 | 8 | 18.18 | 9 | 20.45 |
Total | 44 | 100 | 30 | 68.18 | 14 | 31.82 |
PMTCT Prevention of mother-to-child transmission, HIV Human immune-deficiency virus, % Percentage, IVF In-vitro fertilization